PR
PreveCeutical Medical Inc.
PRVCF · OTC
$0.02 +11.38% (+$0.00)
1M -3.33%
Market Cap $12.1M
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
-
N/A P/E N/A
EV/FFO N/A
EV/EBITDA N/A
Growth
-
N/A EPS growth N/A
Book val. growth N/A
Rev. growth N/A
Profitability
-
N/A Gross margin N/A
FCF margin N/A
Net margin N/A
Quality
57 /100
Average ROIC 339.03%
Asset turnover 0.00x
ROA 109.38%
Debt
0 /100
High Current ratio 0.15x
Int. coverage -10.44x
Debt/Equity N/A
Stability
39 /100
Moderate Beta 0.07x
Profitable years 0
EPS volatility 19.88%
Bulios Scoring popisuje kvalitu a minulost firmy, ne budoucí výnos. Vysoké skóre není nákupní signál. Zjistit více
Zeptejte se StockBota na PRVCF
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Stephen Van Deventer
Employees
7
Headquarters
Vancouver